MJFF Grants XingImaging SynuSight 18F-FD4 PET Tracer for Parkinson’s

MJFF Grants XingImaging SynuSight 18F-FD4 PET Tracer for Parkinson’s

US$1.2 million award accelerates first α-synuclein imaging agent, enabling early Parkinson’s diagnosis and boosting neurodegenerative drug trials.
Japan to start world's first human trial using stem cell to treat Parkinson's

Japan to start world's first human trial using stem cell to treat Parkinson's

Japanese researchers on Monday (Jul 30) announced the world's first human trial using a kind of stem cell to treat Parkinson's disease, building on earlier animal trials.